Gomekli is the second ever FDA-approved treatment for rare tumor disease, NF1-PN and the first to be approved for both adult and pediatric patients.

ICON, which builds homes using 3D printing, has closed on $56 million in Series C funding co-led by Norwest Venture Partners ...

The U.S. Food and Drug Administration approved Merilog as biosimilar to Novolog for the improvement of glycemic control in adults and pediatric ...

Luigi Mangione spoke out for the first time since his arrest, releasing a statement on a new website launched by his legal defense team.

Muhdo Group is proud to announce the addition of Randy Oostra, CEO of BlueprintN1 and former President and CEO of ProMedica, ...